Showing results (1-10 of 158) with videos related to
Sort By:
Pageof 16
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio|June 1, 1987
[Microbiological aspects of urinary infections in hospitalized and ambulatory elderly patients]G Santus, C Sottini, M R Inzoli, et al.Europa Medicophysica|October 27, 2005
Nosocomial infections in the rehabilitation departmentG Santus, C Brun, P Viani, et al.Minerva Medica|September 29, 1981
[Usefulness of plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies]G Santus, F Pirali, M R InzoliDrugs Under Experimental and Clinical Research|January 1, 1987
Comparison of the in vitro antibacterial activity of teicoplanin and vancomycin against gram-positive cocciG Ravizzola, F Pirali, I Foresti, et al.Journal of Chemotherapy (Florence, Italy)|December 1, 1994
In vitro antibacterial activity of the new quinolone Bay y3118 against clinical isolatesG Ravizzola, R Pizzi, F Pirali, et al.Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1985
Resistance to beta-lactam antibacterial agents in hospitalsM Gelmi, I Foresti, G Ravizzola, et al.The New Microbiologica|July 1, 1997
Isolation of HTLV-1 from an aggressive form of ATL in a Romanian patient not at risk of infection and with seronegative family membersN Manca, P Ferremi, N De Simone, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1989
Antibacterial activity of the new carbapenem meropenem (SM-7338) against clinical isolatesG Ravizzola, G Pinsi, R Gonzales, et al.Journal of Clinical Microbiology|January 1, 1989
Evaluation of BACTEC system for urine culture screeningD Colombrita, G Ravizzola, F Pirali, et al.Drugs Under Experimental and Clinical Research|January 1, 1989
Rufloxacin (MF-934): in vitro and in vivo antibacterial activityG Ravizzola, G Pinsi, F Pirali, et al.Pageof 16